Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bausch + Lomb Corp.

13.73
-0.1600-1.15%
Post-market: 13.730.00000.00%16:42 EDT
Volume:530.96K
Turnover:7.26M
Market Cap:4.84B
PE:-15.24
High:13.79
Open:13.70
Low:13.53
Close:13.89
Loading ...

GUIDANCE: (BLCO) Bausch + Lomb Expects Full Year 2025 Revenue Range $4.95B - $5.05B, vs. FactSet Est of $5.02B

MT Newswires Live
·
19 Feb

Earnings Flash (BLCO) Bausch + Lomb Posts Q4 Revenue $1.28B, vs. FactSet Est of $1.26B

MT Newswires Live
·
19 Feb

Bausch & Lomb Q4 Adj $0.25 Beats $0.24 Estimate, Sales $1.28B Beat $1.26B Estimate

Benzinga
·
19 Feb

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
18 Feb

Unlocking Q4 Potential of Bausch + Lomb (BLCO): Exploring Wall Street Estimates for Key Metrics

Zacks
·
17 Feb

Bausch + Lomb Corp expected to post earnings of 24 cents a share - Earnings Preview

Reuters
·
17 Feb

Sector Update: Health Care Stocks Retreat Thursday Afternoon

MT Newswires Live
·
07 Feb

Bausch + Lomb Says it Won't Go Private at This Time; Shares Fall

MT Newswires Live
·
06 Feb

Bausch Health Provides Update on Strategic Alternatives

ACCESS Newswire
·
06 Feb

Bausch Health Q4 Results to Focus on 2025 Outlook, Potential Full Separation of Bausch + Lomb, RBC Says

MT Newswires Live
·
31 Jan

Stifel Nicolaus Remains a Hold on Bausch + Lomb Corporation (BLCO)

TIPRANKS
·
30 Jan

RBC Capital Issues a Buy Rating on Bausch + Lomb Corporation (BLCO)

TIPRANKS
·
29 Jan

RBC Trims Price Target on Bausch + Lomb to $22 From $23, Keeps Outperform Rating

MT Newswires Live
·
29 Jan

Morgan Stanley Keeps Their Hold Rating on Bausch + Lomb Corporation (BLCO)

TIPRANKS
·
23 Jan

This Bausch + Lomb Insider Increased Their Holding In The Last Year

Simply Wall St.
·
21 Jan

Bausch + Lomb price target raised to $19 from $18 at Barclays

TIPRANKS
·
21 Jan

Bausch + Lomb Bolsters Pipeline With Acquisition Of Whitecap Biosciences

Reuters
·
13 Jan

Bausch + Lomb launches enVista Aspire monofocal, toric intraocular lenses in EU

TIPRANKS
·
13 Jan

Is Bausch + Lomb (BLCO) the Best Medical Stock to Buy Under $20?

Insider Monkey
·
12 Jan

Wells Fargo Sticks to Its Buy Rating for Bausch + Lomb Corporation (BLCO)

TIPRANKS
·
11 Jan